e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Pathology and immunology of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
B cell activating factor and peripheral tolerance in COPD
F. Polverino, A. Rios, A. Jahn, A. Iglesias, C. Crespi, J. Sauleda, A. Agusti, B. Cosio (Cava dei Tirreni, Italy; Palma de Mallorca, Barcelona, Spain)
Source:
Annual Congress 2010 - Pathology and immunology of COPD
Session:
Pathology and immunology of COPD
Session type:
Oral Presentation
Number:
5345
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Polverino, A. Rios, A. Jahn, A. Iglesias, C. Crespi, J. Sauleda, A. Agusti, B. Cosio (Cava dei Tirreni, Italy; Palma de Mallorca, Barcelona, Spain). B cell activating factor and peripheral tolerance in COPD. Eur Respir J 2010; 36: Suppl. 54, 5345
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Definition and history of sarcoidosis
Related content which might interest you:
Overexpression of B cell activating factor (BAFF) in peripheral lung of COPD patients
Source: Annual Congress 2009 - Pathology and immunology of COPD
Year: 2009
Platelet activating factor receptor mRNA in lung epithelial cells stimulated by urban PM10
Source: Annual Congress 2010 - Epithelial cell biology
Year: 2010
Response of novel pan-JAK inhibitor in COPD peripheral blood mononuclear cells
Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs
Year: 2010
Late endothelial progenitor cells are senescent and dysfunctional in COPD due to reduced sirtuin-1 levels
Source: Annual Congress 2011 - Novel mechanisms in COPD
Year: 2011
Increased vascular endothelial growth factor (VEGF) secretion from activated T cells in COPD
Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly?
Year: 2007
Capsazepine inhibits NF-κB subunits in dsRNA-exposed human bronchial epithelial cells from asthmatic and COPD donors
Source: Annual Congress 2011 - Translational models of airway disease
Year: 2011
Reduced nuclear factor-?B repressing factor: a link toward systemic inflammation in COPD},
Source: Eur Respir J 2012; 40: 863-873
Year: 2012
The in vitro effect of vitamin D on peripheral blood mononuclear cell cytokine expression in COPD
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012
Oxidative stress-induced corticosteroid insensitivity is reversed by formoterol via inhibition of PI3K signalling in peripheral blood mononuclear cells from patients with COPD and severe asthma
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011
Annexin A1 signalling regulates neutrophil responses: a link to COPD pathogenesis
Source: Annual Congress 2011 - Innate immune responses in COPD and severe asthma: new targets for therapy?
Year: 2011
Corticosteroid-dependent transcription is reduced by inflammatory stimuli in human airway epithelial cells: Rescue by long-acting β
2
-adrenoceptor agonists
Source: Annual Congress 2011 - Epithelial cells: role in health and disease
Year: 2011
Interleukin-10 expressing regulatory B cells are decreased in blood of smokers and COPD patients
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
Expression and role of the nerve growth factor NGF in pulmonary hypertension
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011
ACE gene polymorphisms, COPD exercise tolerance and response to acute oxygen
Source: Annual Congress 2011 - Altered mechanisms during exercise in disease
Year: 2011
Increased propensity for apoptosis and decreased Bcl-2 in peripheral blood T-cells from COPD patients - effect of corticosteroids?
Source: Eur Respir J 2004; 24: Suppl. 48, 317s
Year: 2004
Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS)
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Bronchial epithelial cells secrete an unknown factor that specifically activate inflammatory cytokine expression from neutrophils and peripheral blood mononuclear cells
Source: Annual Congress 2004 - Epithelial cells: critical regulation of pathogenic processes in disease
Year: 2004
COPD lung contains a sub-population of steroid-insensitive macrophages
Source: Annual Congress 2011 - Macrophages and neutrophils in chronic lung disease
Year: 2011
Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 652s
Year: 2006
Airway epithelial cell P2Y6R-Expression is up-regulated during acute and chronic allergic inflammation and contributes via modulating of CXC8 and IL-6 secretion to development of airway remodelling
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept